SMS Pharmaceuticals Ltd Quarterly Results

Gross Sales

248.2

173.35

196.75

164.45

245.8

Excise Duty

0

0

0

0

0

Net Sales

248.2

173.35

196.75

164.45

245.8

Other Operating Income

0

0

0

0

0

Other Income

1.42

2.13

1.3

1.37

1.65

Total Income

249.62

175.48

198.05

165.82

247.44

Total Expenditure

207.39

140.14

165.28

130.94

212.18

PBIDT

42.23

35.34

32.77

34.88

35.26

Interest

5.07

4.2

4.61

4.67

5.61

PBDT

37.16

31.13

28.16

30.21

29.65

Depreciation

8.64

8.7

8.62

8.38

7.92

Minority Interest Before NP

0

0

0

0

0

Tax

4.65

4.99

4.7

5.3

4.63

Deferred Tax

3.79

0.37

0.98

0.16

1.06

Reported Profit After Tax

20.08

17.08

13.86

16.37

16.05

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

20.32

18.24

14.1

16.48

17.28

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

20.32

18.24

14.1

16.48

17.28

EPS (Unit Curr.)

2.4

2.15

1.67

1.95

2.04

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

8.87

8.47

8.47

8.47

8.47

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

17.01

20.38

16.65

21.21

14.34

PBDTM(%)

14.97

17.95

14.31

18.37

12.06

PATM(%)

8.09

9.85

7.04

9.95

6.52